Journals / Ege Tıp Dergisi / 2003 / Cilt: 42 - Sayı: 3

The effect of pentoxifiline, vitamin C and vitamin E on the organ toxicity of carboplatin

Karboplatine bağlı organ toksisitelerinde pentoksifilin, C vitamini ve E vitamininin etkisi

Pages
143–148
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results indicate that the combination of carboplatin with the vitamin C, vitamin E or pentoxifylline may protect against hepatotoxicity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, the protective effects of pentoxifylline (PTX), vitamin C and vitamin E on carboplatin toxicity were comparatively investigated in different organs and tissues in rats.
📊
Key Findings & Data:Thirty adult rats were divided into 5 groups (n=6), each comprising six animals and the groups were treated daily for five days, by i.p. injections of O, 2 mL saline (Group I), 25 mg/kg carboplatin (Group II), 25 mg/kg carboplatin + 150mg/kg pentoxifylline (Group III), 25 mg/kg carboplatin + 50 mg/kg vitamin C (Group IV) and 25 mg/kg carboplatin + 50 mg/kg vitamin E (Group V).
💡
Conclusion & Impact:These results indicate that the combination of carboplatin with the vitamin C, vitamin E or pentoxifylline may protect against hepatotoxicity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Karboplatin · Sıçanlar · Pentoksifilin

Abstract

In this study, the protective effects of pentoxifylline (PTX), vitamin C and vitamin E on carboplatin toxicity were comparatively investigated in different organs and tissues in rats. Thirty adult rats were divided into 5 groups (n=6), each comprising six animals and the groups were treated daily for five days, by i.p. injections of O, 2 mL saline (Group I), 25 mg/kg carboplatin (Group II), 25 mg/kg carboplatin + 150mg/kg pentoxifylline (Group III), 25 mg/kg carboplatin + 50 mg/kg vitamin C (Group IV) and 25 mg/kg carboplatin + 50 mg/kg vitamin E (Group V). At the end of the treatment, blood samples were collected by direct cardiac puncture and serum was used for the assay of marker enzymes, alanine amino-transferase (ALT), alkaline phosphatase (ALP), direct and indirect bilirubin. Tissue samples were taken and processed by standard histological techniques. At the end of the study, while there were no pathological alterations in the carboplatin group, ALT and ALP activities were significantly increased compared to the control group. There were also no pathological signs in the pentoxifylline, vitamin C and vitamin E groups and ALT, ALP and indirect bilirubin levels were not different from control, but significantly lower than carboplatin groups. These results indicate that the combination of carboplatin with the vitamin C, vitamin E or pentoxifylline may protect against hepatotoxicity.

Özet

Bu çalışmada antineoplastik bir ajan olan karboplatinin sıçanlarda çeşitli organ ve dokular üzerindeki toksisitesi üzerine pentoksifilin (PTX), C ve E vitamininin koruyucu etkileri karşılaştırmalı olarak araştırıldı. Otuz adet sıçan, beş çalışma grubuna (n=6) ayrıldı: Grup I; 0.2 mL serum fizyolojik, grup II; 25 mg/kg karboplatin, Grup III; 25 mg/kg karboplatin + 150 mg/kg pentoksifilin, Grup IV; 25 mg/kg karboplatin + 50 mg/kg C vitamini ve Grup V; 25 mg/kg karboplatin + 50 mg/kg E vitamini intraperitoneal (ip) yolla beş gün süreyle alacak şekilde düzenlendi. Çalışmanın sonunda sıçan serumlarında ALT, ALP, direkt ve indirekt bilirubin seviyelerine bakıldı. Dokular standart histopatolojik yöntemlerle incelendi. Çalışma sonunda histopatolojik yönden karboplatin grubuna ait herhangi bir patolojik bulguya rastlanmazken, serum ALP ve ALT değerlerinin kontrol grubuna göre anlamlı derecede yükseldiği gözlendi. PTX, C ve E vitamini gruplarında ise yine histopatolojik yönden herhangi bir patolojik bulgu gözlenmezken, serum ALP, ALT ve indirekt bilirubin değerlerinin kontrol grubundan farksız, karboplatin grubundan ise istatistiksel olarak anlamlı derecede düşük olduğu saptandı. Karboplatinle birlikte C vitamini, E vitamini veya PTX verilmesinin karaciğer hasarına karşı koruyucu etkili olabileceği sonucuna varıldı.

🔖

Cite This Article

ÖZBEK, H., KÖSEM, M., ERDOĞAN, E., BAYRAM, İ., DURMUŞ, A., DİLEK, İ. (2003). The effect of pentoxifiline, vitamin C and vitamin E on the organ toxicity of carboplatin. Ege Tıp Dergisi, Cilt: 42 - Sayı: 3, 143–148. https://ajindex.com/articles/223392

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Salmon SE, Sartorelli AC. Cancer Chemotherapy. Katzung BG, ed. Basic&Clinical Pharmacology. 8th edition. The McGraw-HİII Companies: 2001: 923 2. Kayaalp SO: Rasyonel tedavi Yönünden Tıbbi Farmakoloji. 9'uncu baskı. Ankara: Hacettepe TAŞ, 2000: 397. 3. Carles J, Nogue M, Domenech M et al. Carboplatin-gemcitabine treatment of patients with transitionai celi carcinoma of the biadder and impaired renal funotion. Oncology 2000; Jun;59(1): 24-27. 4. Chang AY, Hui L, Asbury R et al. Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer. Cancer Chemother Pharmacol 1999; 44 Suppl:S26-28. 5. Shi TZ, Yan JL. Therapeutic effect of carboplatin and etoposide combinative therapy on 123 lung cancer cases. Zhonghua Zhong Liu Za Zhi 1994; Sep;16 (5): 384-386. 6. Holland HK, Dix SP, Geller RB et al. Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive çare. J Clin Oncol 1996; Apr;14 (4): 1156-1164. 7. Ghalie R, VVilliams SF, Valentino LA et al. Tandem peripheral blood progenitor celi transplants as initial therapy for metastatic breast cancer. Biol Blood Marrovv Transpiant 1995; Nov;1 (1): 40-46. 8. Jones RB, Shpall EJ, Ross M et al. High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrovv support: excessive hepatic toxicity. Cancer Chemother Pharmacol 1990; 26 (2): 155-156. 9. Demirer T, İlhan O, Mandel NM et al. A phase I dose escalation study of high-dose thiotepa, meiphalan and carboplatin (TMCb) follovved by autologous peripheral blood stem celi transplantation (PBSCT) in patients with solid tumors and hematologic maiignancles. Bone Marrovv Transpiant 2000; Apr;25 (7): 697-703. 10. VVelborn JL, Kopecky KJ, Meyers FJ et ai. Carbopiatin infusion in relapsed and refractory acute myeloid leukemia—a Southvvest Oncology Group trial. Leukemia 1995; Jui; 9 (7): 1126-1129. 11. Chu G, Mantin R, Shen YM et al. Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management. Cancer 1993; Dec 15; 72 (12): 3707-3714. 12. Ettinger LJ, Krailo MD, Gaynon P al. A phase I study of carboplatin in children with acute leukemia in bone marrovv relapse. A reportfrom the Childrens Cancer Group. Cancer 1993; Aug 1; 72 (3): 917-922. 13. VViedemann GJ, d'Oleire F, Knop E et al. Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia